Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life ...

Enhancing Research Accuracy with High-Purity Recombinant Proteins

AAA Bio’s recombinant proteins, offering high purity, consistency, and reliability for advancing research in drug ...
The Scientist

Harnessing Molecular Farming’s Potential

Stay up to date on the latest science with Brush Up Summaries. Finally, although transgenic animals and mammalian cell culture systems promote optimal expression due to correct protein modifications, ...
JD Supra

Recombinant Host Cells Are Patent-eligible: Federal Circuit Revives Regenxbio’s Gene Delivery Patent

Paige Chandler Ph.D., Karen Potter Ph.D., Jeffrey Schmidt Ph.D. 1. A cultured host cell containing a recombinant nucleic acid molecule encoding an AAV vp1 capsid protein having a sequence comprising ...
clinicaladvisor.com

FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy

Approval allows for use in nonambulatory individuals ≥4 years with a confirmed gene mutation. HealthDay News — The US Food and Drug Administration has expanded the approval of Elevidys ...

Fermbox and Dyadic Launch 1st Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

Our animal-origin free recombinant proteins and enzymes portfolio, developed with Dyadic, augments Fermbox’s strategy ...